Aeterna Zentaris Presents Positive Phase 2 Efficacy And Safety Data For AEZS-108 In Advanced Endometrial Cancer At ENA Meeting In Berlin, Germany

Aeterna Zentaris Inc. (Nasdaq: AEZS; TSX: AEZ) (the “Company”), earlier today, presented Phase 2 positive efficacy and safety data for its compound, AEZS-108, in advanced endometrial cancer. The trial was conducted by the German AGO Study Group and centers in Bulgaria. The presentation was made by Prof…

Community Briefs: Session to discuss menopause

Session to discuss menopauseFLETCHER Park Ridge Health will offer a free Dinner and Learn on menopause, presented by Dr. Krishna Das, F.A.C.O.G., at 5:30 p.m. Wednesday at the Lelia Patterson Center in Fletcher. Dr. Das will discuss the risks and benefits of a variety of treatment options as well as managing symptoms of menopause. The presentation and the light dinner are both free and open …

« Previous Page